Get key updates on stock ratings this week, from Intel's leadership-driven upgrade to Apple's tariff challenges.
Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US ...
Smaller producers will likely pull back on activity if oil prices fall below $60 a barrel, Fred Forthuber, president of OXY ...
Novo Nordisk is also pursuing other indications ... we are featuring today include Moody's Corp. (MCO), Diamondback Energy, Inc. (FANG) and Waste Management, Inc. (WM).
Novo Banco SA, a Portuguese lender that’s majority-owned by Lone Star, said its planned initial public offering could take ...
Novo Nordisk shares fell after the pharmaceutical giant released fresh trial results for its CagriSema developmental weight-loss drug. The Danish company said CagriSema helped obese or overweight ...
Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...
Novo Nordisk is cutting the cost of its blockbuster weight-loss drug Wegovy in half for U.S. patients paying cash through its direct-to-patient online pharmacy, as competition in the highly ...